E. Valvo

1.5k total citations
61 papers, 1.0k citations indexed

About

E. Valvo is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Valvo has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Nephrology, 20 papers in Cardiology and Cardiovascular Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Valvo's work include Blood Pressure and Hypertension Studies (18 papers), Parathyroid Disorders and Treatments (11 papers) and Dialysis and Renal Disease Management (10 papers). E. Valvo is often cited by papers focused on Blood Pressure and Hypertension Studies (18 papers), Parathyroid Disorders and Treatments (11 papers) and Dialysis and Renal Disease Management (10 papers). E. Valvo collaborates with scholars based in Italy, United States and Switzerland. E. Valvo's co-authors include Giuseppe Maschio, Antonio Lupo, Michele Stornello, Nicola Tessitore, Lamberto Oldrizzi, C. Loschiavo, Antonia Fabris, Carlo Rugiu, Linda Gammaro and Angela D’Angelo and has published in prestigious journals such as American Journal of Clinical Nutrition, Kidney International and The American Journal of Medicine.

In The Last Decade

E. Valvo

55 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Valvo Italy 20 514 302 241 200 138 61 1.0k
N. El Esper France 17 649 1.3× 298 1.0× 288 1.2× 212 1.1× 135 1.0× 47 1.2k
Lamberto Oldrizzi Italy 18 563 1.1× 154 0.5× 275 1.1× 111 0.6× 137 1.0× 65 1.0k
H. A. Koomans Netherlands 17 576 1.1× 368 1.2× 386 1.6× 181 0.9× 74 0.5× 35 1.2k
Per‐Ola Attman Sweden 21 518 1.0× 199 0.7× 184 0.8× 382 1.9× 97 0.7× 44 1.3k
Carol Weerts United States 8 812 1.6× 122 0.4× 242 1.0× 100 0.5× 233 1.7× 9 1.3k
Stanisław Czekałski Poland 14 583 1.1× 235 0.8× 79 0.3× 252 1.3× 94 0.7× 67 1.1k
Marco DʼAmico Italy 13 534 1.0× 240 0.8× 180 0.7× 180 0.9× 47 0.3× 30 993
Satoru Kuriyama Japan 19 552 1.1× 324 1.1× 83 0.3× 275 1.4× 76 0.6× 83 1.2k
M. Temmar France 8 983 1.9× 347 1.1× 259 1.1× 169 0.8× 106 0.8× 9 1.7k
H Bucht Sweden 19 442 0.9× 179 0.6× 163 0.7× 105 0.5× 82 0.6× 55 937

Countries citing papers authored by E. Valvo

Since Specialization
Citations

This map shows the geographic impact of E. Valvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Valvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Valvo more than expected).

Fields of papers citing papers by E. Valvo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Valvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Valvo. The network helps show where E. Valvo may publish in the future.

Co-authorship network of co-authors of E. Valvo

This figure shows the co-authorship network connecting the top 25 collaborators of E. Valvo. A scholar is included among the top collaborators of E. Valvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Valvo. E. Valvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribichini, Flavio, Angela Ferrara, Michele Pighi, et al.. (2014). Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient. Journal of Nephrology. 27(6). 713–716. 3 indexed citations
2.
Zanoli, Luca, Stefania Rastelli, Gaetano Inserra, et al.. (2014). Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis. 234(2). 346–351. 57 indexed citations
3.
Ribichini, Flavio, Michele Pighi, Carlo Zivelonghi, et al.. (2013). Invasive assessment of renal artery atherosclerotic disease and resistant hypertension before renal sympathetic denervation. Journal of Nephrology. 26(4). 799–801. 5 indexed citations
4.
Sala, Carla, Valeria Bedogna, Linda Gammaro, et al.. (2003). Central role of vasopressin in sodium/water retention in hypo- and hypervolemic nephrotic patients: A unifying hypothesis. Journal of Nephrology. 17(5). 653–657. 6 indexed citations
5.
Leone, Roberto, et al.. (1999). Nimesulide and renal impairment. European Journal of Clinical Pharmacology. 55(2). 151–154. 19 indexed citations
6.
7.
Bedogna, Valeria, et al.. (1990). Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney International. 38(1). 101–107. 55 indexed citations
8.
Valvo, E., et al.. (1990). Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension. Journal of Hypertension. 8(11). 991–995. 13 indexed citations
9.
Stornello, Michele, et al.. (1989). Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria. Journal of Hypertension. 7(6). S314–315. 15 indexed citations
10.
Stornello, Michele, et al.. (1988). Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria. Journal of Hypertension. 6(4). S464–466. 16 indexed citations
11.
Valvo, E., Linda Gammaro, Paola Antonini, et al.. (1987). Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.. PubMed. 25(12). 656–9. 5 indexed citations
12.
Maschio, Giuseppe, Lamberto Oldrizzi, Carlo Rugiu, et al.. (1987). Factors affecting progression of renal failure in patients on long-term dietary protein restriction.. PubMed. 22. S49–52. 19 indexed citations
13.
Loschiavo, C., Antonia Fabris, Silvano Adami, et al.. (1985). Effects of Continuous Ambulatory Peritoneal Dialysis (CAPD) on Renal Osteodystrophy. Peritoneal Dialysis International. 5(1). 53–55. 12 indexed citations
14.
Pistolesi, G. F., et al.. (1985). Venous digital subtraction angiography in the evaluation of renovascular hypertension.. PubMed. 5(2). 120–4. 4 indexed citations
15.
Maschio, Giuseppe, Lamberto Oldrizzi, Nicola Tessitore, et al.. (1982). Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney International. 22(4). 371–376. 158 indexed citations
16.
Loschiavo, C., Antonio Lupo, Tullio Faraggiana, et al.. (1981). Clinical significance of plasma factor VIII levels in renal disease.. PubMed. 16(4). 200–6. 1 indexed citations
17.
Maschio, Giuseppe, Angela D’Angelo, Elena Ossi, et al.. (1976). [Aspects of phosphorus-calcium metabolism in obstructive nephropathy].. PubMed. 22(1). 38–44. 1 indexed citations
18.
Bonucci, E., Giorgio Gherardi, G. Mioni, et al.. (1975). [Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure].. PubMed. 22(2-3). 99–108. 3 indexed citations
19.
Maschio, G, E. Bonucci, G. Mioni, et al.. (1974). Biochemical and Morphological Aspects of Bone Tissue in Chronic Renal Failure. ˜The œNephron journals/Nephron journals. 12(6). 437–448. 10 indexed citations
20.
Mioni, G., Elena Ossi, Anna D’Angelo, et al.. (1973). Aspects of phosphate metabolism in kidney disease. The pre-eminence of extrarenal factors.. PubMed. 18(6). 491–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. El Esper Breakdown of academic impact, for papers by Lamberto Oldrizzi Breakdown of academic impact, for papers by H. A. Koomans Breakdown of academic impact, for papers by Per‐Ola Attman Breakdown of academic impact, for papers by Carol Weerts Breakdown of academic impact, for papers by Stanisław Czekałski Breakdown of academic impact, for papers by Marco DʼAmico Breakdown of academic impact, for papers by Satoru Kuriyama Breakdown of academic impact, for papers by M. Temmar Breakdown of academic impact, for papers by H Bucht
Rankless by CCL
2026